19 January 2024: This investment view is now outdated. Reach out to your advisor for our current views.

building with hexagonal windows
pick leaders from disruption icon

We expect some of the highest returns in equity markets over the decade ahead to come from those companies that can harness new technologies to grow markets, dislodge incumbents, or slash costs. Successfully identifying these “leaders from disruption” is critical to boosting long-term portfolio potential. We expect the decade ahead to see a wave of disruption rippling across industries from technology to energy to healthcare.

Technology disruption

The arrival of mainstream AI services accessible to consumers has driven significant investment into the world’s largest technology leaders, crowning the first trillion-dollar AI company in the process. The "Magnificent 7," mostly AI beneficiaries, rallied 107% in 2023. With access to all the computing, financial, human, and data resources they need to grow and exploit the potential of generative AI, the largest players could grow even larger over the coming decade, in our view.

But this is not a story limited to mega-cap tech. We think technological disruption will be an enduring theme that spawns new opportunities and leaders across sectors in the decade to come.

From an investment perspective, the beneficiaries of AI can be broken down into four areas: infrastructure and input providers (cloud), hardware (GPU manufacturers), operators and enablers (large language models), and application beneficiaries (text generation, programming, image/video generation).

We therefore see AI-related opportunities across a range of software, internet, and semiconductor stocks. Based on Bloomberg Intelligence data, we now expect global AI demand to grow from USD 28bn in 2022 to USD 420bn by 2027—a 72% annual growth rate and a fifteenfold increase in just five years. In that time, we think the applications and models segment will grow by 152%. 

Recent company product and earnings announcements in the software sector have provided a peek into AI’s monetization potential. For example, new “copilots” are being rolled out rapidly. These are AI companion tools integrated within office workflow software to boost employee productivity, performing tasks that range from finding information to creating content. The ability to charge additional monthly fees for copilot add-ons gives subscription-based software companies an expanded scope for AI monetization.

Energy disruption

Concerns about climate change, national security, and advancing technology are driving global decarbonization. Creating an economy free of carbon emissions and transitioning to clean fuels is a complex undertaking. It will require investment in power generation, energy infrastructure, transport, industry, buildings, and heating and cooling systems, with the adoption of green technologies to achieve net-zero targets. We think investors will gain most through exposure to a number of these themes given the different stages of development across countries and sectors.

We expect global solar capacity to triple in the coming years from the current 1,000 GW, increasing the share of renewables in the global power mix. The share of renewables in electricity generation has already risen from 20% to 30% over the past decade. Investors can tap solar opportunities through diversified exposure to greentech, long-term exposure to the energy efficiency value chain, or more concentrated exposure to smart energy solutions.

We expect electrified vehicles (including battery electric and hybrid) to make up around 30% of global auto sales by 2025 and more than 60% by 2030, driven by incremental technological developments and regulatory changes. The electric vehicle value chain is integral to greentech investment themes, especially in Asia and Europe.

Meanwhile, decarbonizing the heating and cooling systems of buildings and factories will require strong emphasis on energy-efficiency investment. When the limits of hardware are reached, software can often be used to enhance energy efficiency. This should open up opportunities for companies that gather digital data and provide enabling technologies.

Beyond public markets, investors can tap into energy disruption opportunities in private markets, including in renewable infrastructure development, energy networks, storage, carbon capture, energy efficiency, and circular economy solutions.

The transition to renewables is under way
Primary energy consumption by fuel source, share of total, in %

A chart showing that the transition to renewables is under way, displaying primary energy consumption by fuel source, share of total, in %
Source: Energy Institute Statistical Review of World Energy 2023, UBS, as of November 2023

Healthcare disruption

The healthcare sector will likely be a key source of disruptive innovation over the next decade. Aging populations will increase the demand for healthcare services and treatments, while tighter government budgets will necessitate new approaches to care delivery.

We see biological innovation and healthcare technology application as prime areas. Diversified exposure makes particular sense given that many companies in this field are small- or mid-cap.

In addition to obesity remedies, which grabbed investors’ attention in 2023, we see opportunities in cancer treatment, rare diseases, immunology, and neurology. Companies have developed various new treatments that are now either reaching the market or close to approval, including antibody-drug conjugates, bispecific and multi-specific antibodies, and even cell therapy approaches for immunological conditions.

Meanwhile, increased connectivity and computational power are also leading to significant development. Trends include miniaturization, robotics, greater ease of interaction with patients, and improved access. The biopharma industry is also exploring AI-driven approaches to increase the output of the drug discovery process, develop new diagnostic approaches, or personalize medicines, although it is too early to see any tangible changes in drug discovery and approval rates.

When investing in healthcare disruption, we think it is important to keep a diversified exposure to various areas of innovation. Most of the disruptors are small companies, and tighter financial conditions can disproportionately affect short-term stock performance of said companies. Combining investments in the “disruptors” with investments in the “adopters”—more established companies that are using the new technologies—can be a lower-risk way of capturing the benefits of innovation.

We also see opportunity for investors to diversify across major subsectors (biopharma, medtech and tools, and services), and by geography, potentially enabling them to capture the growth in emerging market healthcare. Investors able to lock up capital for longer can also diversify beyond listed companies, given the significant role of private markets in funding early-stage research. Allocations to health-related investments across private and public markets could also benefit sustainability-focused portfolios.


More investment ideas

Other chapters

Chapter 1 The Year Ahead

Discover our scenarios, key questions, and forecasts for 2024, plus take a look back at 2023.

Chapter 2 The Decade Ahead

Dive into the “Five Ds,” scenarios and key questions for the future, and our asset class expectations.

Chapter 4 Getting in balance

Find out how we think investors can protect and grow their wealth for the year and decade ahead.

Already a client of UBS?

Want to print this report?

This report has been prepared by UBS AG, UBS AG London Branch, UBS Switzerland AG, UBS Financial Services Inc. (UBS FS), UBS AG Singapore Branch, UBS AG Hong Kong Branch, and UBS SuMi TRUST Wealth Management Co., Ltd..